Jillian K. Warejko,Weizhen Tan,Ankana Daga,David Schapiro,Jennifer A. Lawson,Shirlee Shril,Svjetlana Lovric,Shazia Ashraf,Jia Rao,Tobias Hermle,Tilman Jobst-Schwan,Eugen Widmeier,Amar J. Majmundar,Ronen Schneider,Heon Yung Gee,J. Magdalena Schmidt,Asaf Vivante,Amelie T. van der Ven,Hadas Ityel,Jing Chen,Carolin E. Sadowski,Stefan Kohl,Werner L. Pabst,Makiko Nakayama,Michael J. G. Somers,Nancy M. Rodig,Ghaleb Daouk,Michelle Baum,Deborah R. Stein,Michael A. Ferguson,Avram Z. Traum,Neveen A. Soliman,Jameela A. Kari,Sherif El Desoky,Hanan Fathy,Martin Zenker,Sevcan A. Bakkaloglu,Dominik Mueller,Aytul Noyan,Fatih Ozaltin,Melissa A. Cadnapaphornchai,Seema Hashmi,Jeffrey Hopcian,Jeffrey B. Kopp,Nadine Benador,Detlef Bockenhauer,Radovan Bogdanovic,Natasa Stajic,Gil Chernin,Robert Ettenger,Henry Fehrenbach,Markus Kemper,Reyner Loza Munarriz,Ludmila Podracka,Rainer Buscher,Erkin Serdaroglu,Velibor Tasic,Shrikant Mane,Richard P. Lifton,Daniela A. Braun,Friedhelm Hildebrandt

Abstract:Background and objectives Steroid-resistant nephrotic syndrome overwhelmingly progresses to ESRD. More than 30 monogenic genes have been identified to cause steroid-resistant nephrotic syndrome. We previously detected causative mutations using targeted panel sequencing in 30% of patients with steroid-resistant nephrotic syndrome. Panel sequencing has a number of limitations when compared with whole exome sequencing. We employed whole exome sequencing to detect monogenic causes of steroid-resistant nephrotic syndrome in an international cohort of 300 families. Design, setting, participants, & measurements Three hundred thirty-five individuals with steroid-resistant nephrotic syndrome from 300 families were recruited from April of 1998 to June of 2016. Age of onset was restricted to <25 years of age. Exome data were evaluated for 33 known monogenic steroid-resistant nephrotic syndrome genes. Results In 74 of 300 families (25%), we identified a causative mutation in one of 20 genes known to cause steroid-resistant nephrotic syndrome. In 11 families (3.7%), we detected a mutation in a gene that causes a phenocopy of steroid-resistant nephrotic syndrome. This is consistent with our previously published identification of mutations using a panel approach. We detected a causative mutation in a known steroid-resistant nephrotic syndrome gene in 38% of consanguineous families and in 13% of nonconsanguineous families, and 48% of children with congenital nephrotic syndrome. A total of 68 different mutations were detected in 20 of 33 steroid-resistant nephrotic syndrome genes. Fifteen of these mutations were novel. NPHS1, PLCE1, NPHS2, and SMARCAL1 were the most common genes in which we detected a mutation. In another 28% of families, we detected mutations in one or more candidate genes for steroid-resistant nephrotic syndrome. Conclusions Whole exome sequencing is a sensitive approach toward diagnosis of monogenic causes of steroid-resistant nephrotic syndrome. A molecular genetic diagnosis of steroid-resistant nephrotic syndrome may have important consequences for the management of treatment and kidney transplantation in steroid-resistant nephrotic syndrome.

Phenotypic quantification of Nphs1-deficient mice

Quantifiable and reproducible phenotypic assessment of a constitutive knockout mouse model for congenital nephrotic syndrome of the Finnish type

Quantitative phenotyping of Nphs1 knockout mice as a prerequisite for gene replacement studies

Mutations in Multiple Components of the Nuclear Pore Complex Cause Nephrotic Syndrome

NPHS Mutations in Pediatric Patients with Congenital and Steroid-Resistant Nephrotic Syndrome

Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome

Mutations in Sphingosine-1-phosphate Lyase Cause Nephrosis with Ichthyosis and Adrenal Insufficiency

Analysis of 24 Genes Reveals a Monogenic Cause in 11.1% of Cases with Steroid-Resistant Nephrotic Syndrome at a Single Center

Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a "Patient-Specific" Approach

GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome.

Nephrotic Syndrome in a Child With NPHS2 Mutation

Mutations In Nup160 Are Implicated In Steroid-Resistant Nephrotic Syndrome

The Clinical and Genetic Features in Chinese Children With Steroid-Resistant or Early-Onset Nephrotic Syndrome: A Multicenter Cohort Study

Mutations in Six Nephrosis Genes Delineate a Pathogenic Pathway Amenable to Treatment.

Whole-exome sequencing of a multicenter cohort identifies genetic changes associated with clinical phenotypes in pediatric nephrotic syndrome

A novel mutation in NPHS2 gene identified in a Chinese pedigree with autosomal recessive steroid-resistant nephrotic syndrome.

Genetic Variations and Clinical Features of <i>NPHS1</i>-Related Nephrotic Syndrome in Chinese Children: A Multicenter, Retrospective Study

Genetic Variations and Clinical Features of NPHS1-Related Nephrotic Syndrome in Chinese Children: A Multicenter, Retrospective Study

NPHS1 and NPHS2 Gene Mutations in Chinese Children With Sporadic Nephrotic Syndrome

Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis

Monogenic Causes Identified in 23.68% of Children with Steroid-Resistant Nephrotic Syndrome: A Single-Centre Study